8-K: Perfect Moment raises $12M via loan and equity deal

Sentiment:

Financing Announcement


Perfect Moment secured a $10M senior secured revolver at 12% and a $2M equity investment with warrants, adding liquidity while accepting strict covenants and potential dilution.

Capital raiseDebt: $10,000,000 senior secured revolving credit facility, 24‑month term, 12% interest, 1.50% undrawn fee; first‑lien on substantially all assets.Equity: $2,000,000 private placement of 6,060,606 common shares at $0.33 per share to Krane Capital.Warrants: Krane Warrants for up to 8,276,944 shares at $0.40; X3 Warrants for 1,864,753 shares at $0.46822; both expire August 27, 2028.Registration: Registration Rights Agreement to register the purchased shares and the shares underlying both warrant issuances.

Summary

  • Entered a $10,000,000 senior secured revolving credit facility on March 30, 2026, with X3 Higher Moment Fund LLC (agent) and Krane Capital LLC; 24‑month term, maturing March 30, 2028.
  • Fixed interest rate of 12.0% per annum, payable monthly in arrears; 1.50% per annum commitment fee on daily unused amounts.
  • Facility secured by a first‑priority perfected lien on substantially all existing and future assets of the company and guarantors (PMUK, PMA, PMI, PMUSA).
  • Initial proceeds repay related‑party bridge notes totaling $5,089,960 (Max Gottschalk note dated Aug 8, 2025 and Max & Jane Gottschalk note dated Aug 18, 2025); remaining availability for working capital.
  • Equity financing via Securities Purchase Agreement with Krane Capital for 6,060,606 common shares at $0.33 per share ($2,000,000 gross), plus warrants to purchase up to 8,276,944 shares at $0.40; shares and warrants to be issued on or before May 8, 2026.
  • Issued (on or before May 8, 2026) to X3 Higher Moment Fund LLC warrants to purchase 1,864,753 shares at $0.46822; both warrant series expire August 27, 2028 and include 9.99% beneficial ownership caps (adjustable up to 19.99%).
  • Registration Rights Agreement requires the company to register the Krane shares and both warrant share classes; initial filing targeted within 15 days of issuance.
  • Financial covenants include minimum trailing‑12‑month revenue of $20,000,000 (tested monthly, with a 3‑month average compliance provision) and minimum current assets of $10,000,000; equity cure permitted up to three times.
  • Cash sweep triggers if Twelve‑Month Average Revenue falls below $21,000,000 or current assets below $12,500,000 at month‑end; during a Cash Sweep Period, 100% of Excess Cash Flow is applied to loan prepayment.
  • Option for mandatory warrant exercise begins on the second anniversary of the respective Commencement Date if price hurdles and an effective resale registration are in place.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as modestly positive: liquidity and refinancing of insider debt are constructive, but high cost of capital, covenants, and dilution risk temper upside.

Positives

  • Adds $10,000,000 of committed liquidity for 24 months, improving near‑term financial flexibility.
  • Blended financing includes $2,000,000 equity at $0.33 per share and long‑dated warrants, diversifying capital sources.
  • First‑lien revolver provides working capital support while refinancing $5,089,960 of higher‑risk related‑party bridge debt.
  • Clear covenant framework with defined equity cure rights (up to three cures) limits default risk from seasonal or timing volatility.
  • Registration rights established to facilitate future resale of the Krane shares and both warrant share classes.

Negatives

  • Cost of capital is high: 12.0% fixed interest plus a 1.50% per annum unused commitment fee.
  • Significant potential dilution from 6,060,606 new shares and up to 10,141,697 warrant shares (8,276,944 Krane + 1,864,753 X3).
  • Strict covenants (revenue and current asset tests) and cash sweep mechanics could constrain flexibility if operating performance softens.
  • Facility is secured by a first‑priority lien on substantially all assets, elevating refinancing risk if covenants are breached.

Risks

  • Minimum TTM revenue covenant of $20,000,000 and minimum current assets of $10,000,000; failure triggers default unless cured.
  • Cash Sweep Trigger Event if Twelve‑Month Average Revenue < $21,000,000 or current assets < $12,500,000, diverting Excess Cash Flow to debt prepayment.
  • Change of control, cross‑defaults, judgments, insolvency events, and other customary events of default could accelerate the facility.
  • Equity cures limited to three occurrences and amounts necessary to pass covenant tests.
  • Mandatory prepayments apply to proceeds from non‑ordinary course asset sales, certain indebtedness, and during Cash Sweep Periods.

Future Outlook

Management plans to use the revolver and equity proceeds to strengthen liquidity, repay insider bridge debt, fund working capital, and support growth initiatives; resale registration of the equity and warrant shares is planned under a Registration Rights Agreement.

Management Comments

  • Executive Chairman Max Gottschalk highlighted that the financing enhances financial flexibility and supports the strategy and operating progress toward sustainable profitability.
  • CFO/COO Chath Weerasinghe noted the $12 million package strengthens liquidity, provides flexibility for product and go‑to‑market investments, and aligns with disciplined long‑term value creation.

Industry Context

StockSavvy.ai notes that small-cap consumer brands frequently rely on private credit with double‑digit coupons and warrant coverage. The 12% rate and first‑lien security are typical for micro‑cap apparel, while the $0.33 equity price (press release cites a 75% premium to the prior close) and long‑dated warrants mirror market norms for hybrid debt‑equity financings aimed at liquidity and growth support.

Comparison to Industry Standards

  • Interest Cost: A 12% fixed rate sits within the 10–14% range often seen for first‑lien private credit to micro‑cap consumer names (e.g., Revolve‑style specialty lenders).
  • Commitment Fee: 1.50% on undrawn balances is slightly above the 0.5–1.0% seen at larger borrowers, but consistent with smaller, higher‑risk issuers.
  • Warrant Coverage: 10.1M+ potential warrant shares (plus 6.1M equity shares) is a typical equity kicker for private lenders/investors at this scale; comparable micro‑cap consumer financings often include 10–20% fully‑diluted coverage.
  • Security Package: First‑priority lien on substantially all assets and cross‑border guarantees match market practice for asset‑backed revolvers in apparel with inventory/receivables collateral.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board Observer RightX3 Higher Moment Fund LLC obtains the right to appoint a non‑voting observer to the boards of the company and its subsidiaries while the loan or X3 warrants are outstanding.2026-03-30Increases lender oversight and information rights; no voting control but added influence over governance cadence.
Registration RightsCompany agrees to register Krane’s shares and the shares underlying the Krane and X3 warrants for resale.2026-03-30Facilitates future secondary liquidity; potential selling pressure upon effectiveness.

Related Party Transactions

  • Initial revolver proceeds repay $3,389,960 bridge note to Max Gottschalk (dated August 8, 2025) and $1,700,000 bridge note to Max & Jane Gottschalk (dated August 18, 2025), totaling $5,089,960.

Stakeholder Impact

  • Shareholders: Near‑term liquidity support offsets dilution risk from 6.06M new shares and up to 10.14M warrant shares; resale registration could increase trading liquidity.
  • Creditors: New first‑lien lenders obtain strong collateral coverage; related‑party bridge lenders repaid.
  • Employees/Suppliers: Liquidity and working capital funding should stabilize operations; covenants and cash sweeps may constrain discretionary spending if triggers are hit.
  • Customers: Continued funding supports inventory and product development, potentially improving service levels.
  • Insiders: Related‑party notes repaid; warrants include beneficial ownership caps to limit concentration.

Next Steps

  • Issue Krane shares and both warrant series on or before May 8, 2026.
  • File resale registration statement within 15 days of issuance pursuant to the Registration Rights Agreement.
  • Implement covenant compliance and reporting (monthly revenue/current assets tests; Excess Cash Flow sweeps if triggered).
  • Deploy revolver availability for working capital and operational initiatives after repayment of bridge notes.

Key Dates

DateDescription
2025-08-08Bridge note to Max Gottschalk ($3,389,960) used for repayment
2025-08-18Bridge note to Max & Jane Gottschalk ($1,700,000) used for repayment
2026-03-30Loan Agreement executed; $10,000,000 revolver closing
2026-05-08Deadline to issue 6,060,606 Krane shares and 8,276,944 Krane warrants; X3 warrants issuance deadline
2028-03-30Loan Maturity Date
2028-08-27Expiration of both X3 and Krane warrant series (5:00 p.m. ET)

Recommendation

hold

Improved liquidity and repayment of insider debt are constructive, and the equity was placed at a premium; however, the facility’s 12% cost, strict covenants, cash sweep triggers, and sizable potential dilution warrant a balanced stance until execution against the revenue and current asset covenants is demonstrated and registration-related overhang is better understood.

Keywords

revolving credit facility, private placement, warrants, registration rights, first lien, commitment fee, minimum revenue covenant, current assets covenant, consumer apparel, PMNT

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.